Images List Premium Download Classic

Adverse Event

Adverse Event-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Seatbelt buckle system
July 20, 2017 - N°20170203715

A seatbelt buckle system for law enforcement use, wherein the female portion of the buckle is located at the end of a segment which is in a generally upright and readily-accessible position to assure the safe and expeditious restraint of an individual. The individual securing the occupant is advantageously less prone to adverse events such as unwanted contact with or ...
NEW Pharmaceutical composition for preventing or treating skin rash
Dong-a University Research Foundation For Industry-academy Cooperation
July 20, 2017 - N°20170202917

Provided is a method for preventing or treating skin rash comprising administering to a subject in need thereof epidermal growth factor as an active ingredient. The skin rash includes a skin disorder caused by administering an epidermal growth factor receptor inhibitor, such as erlotinib, as an adverse event.
Methods for predicting response to treatment
Interleukin Genetics, Inc.
July 13, 2017 - N°20170198350

The present invention provides stratification methods and kits to identify whether an individual having an inflammation-related disorder has genotype-specific differential expression of il-1, i. E., is a “high” or “low” producer of il-1, such that s/he can be provided an appropriate anti-inflammatory drug and at an appropriate dose. The stratification of ...
Adverse Event Patent Pack
Download + patent application PDFs
Adverse Event Patent Applications
Download + Adverse Event-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Adverse Event-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Drug efficacy analysis system and drug efficacy analysis method
Tokyo Women's Medical University
June 08, 2017 - N°20170161469

The present invention enables statistical analysis of medical practice data with a small number of samples. The following steps are included: a model creation step in which a patient's factor information that is factor information relating to occurrence of an adverse event and includes test values before medication is regression-analyzed and a transition of test value after medication is modeled; ...
Hospital operations system
Qwaltec, Llc
June 08, 2017 - N°20170161443

A hospital operations system is provided which centralizes, processes, prioritizes, and presents vast data generated by hospital systems and software applications and partially controls devices, alerts, and overall patient care within hospital systems for greater efficiency and provision of improved patient care, patient safety, and hospital efficiency beyond what currently exists. The hospital operations system capabilities are enabled via dedicated ...
Fail-safe lighting control system
Qwaltec, Llc
June 01, 2017 - N°20170156189

A light fixture can include at least one light source, and at least one power supply that receives primary power, where the at least one power source generates final power using the primary power, where the at least one power supply delivers the final power to the at least one light source. The light fixture can also include a controller ...
Adverse Event Patent Pack
Download + patent application PDFs
Adverse Event Patent Applications
Download + Adverse Event-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Adverse Event-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Providing status of user devices during an adverse event
Qwaltec, Llc
May 04, 2017 - N°20170127232

A method begins by a processing module identifying a geographic area of an adverse condition and identifying a user device of a plurality of user devices potentially associated with the identified geographic area. The method continues with the processing module issuing a safety notification to the user device, where the safety notification includes one or more of the identified geographic ...
Materials and methods for differential treatment of cancer
Serametrix Corporation
May 04, 2017 - N°20170121776

The present invention concerns differential therapeutic treatment of cancer patients based on prognostic antigen/antibody profiles used for predicting (prognosticating) a clinical response (efficacy) and/or adverse event to an immunotherapy for treatment of a malignancy in a subject, and for treating or delaying the onset or relapse of a malignancy in a subject.
Methods and systems for adverse event prediction using pump operating data
Heartware, Inc.
May 04, 2017 - N°20170119256

The present disclosure provides for each of a method of characterizing divergence of a monitored flow rate of blood through an implantable blood pump, and a method of predicting an upcoming adverse cardiac event using operating data of the blood pump, such as the characterized divergence data. Predicting an upcoming adverse cardiac event may be further based on similar operating ...
Prediction of adverse drug events
International Business Machines Corporation
April 27, 2017 - N°20170116390

Embodiments include method, systems and computer program products for predicting adverse drug events on a computational system. Aspects include receiving known drug data from drug databases and one or more of a candidate drug, a drug pair, and a candidate drug-patient pair. Aspects also include calculating an adverse event prediction rating representing a confidence level of an adverse drug event ...
Systems and methods for dynamically generated genomic decision support for individualized medical treatment
Aetna Inc.
April 27, 2017 - N°20170116379

Optimization of therapeutic outcomes is disclosed. By analyzing molecular genomic sequence data from an individual relative to a pre-defined knowledge base as well as dynamically generated analyses from comparison to a set of other individuals and molecular genomic sequence data of those other individuals along with their therapeutic history and clinical outcome, medication selection for optimum therapeutic outcomes is achieved. ...
Prediction of adverse drug events
International Business Machines Corporation
April 27, 2017 - N°20170116376

Embodiments include method, systems and computer program products for predicting adverse drug events on a computational system. Aspects include receiving known drug data from drug databases and one or more of a candidate drug, a drug pair, and a candidate drug-patient pair. Aspects also include calculating an adverse event prediction rating representing a confidence level of an adverse drug event ...
Use of serelaxin to reduce gdf-15
Novartis Ag
April 13, 2017 - N°20170100460

Growth differentiation factor 15 (gdf-15) is a stress-responsive cytokine known to be associated with adverse events in heart failure patients. The use of serelaxin has been shown to affect gdf-15 levels at baseline and decreases in gdf-15 levels over time. Measuring gdf-15 levels allows a healthcare provider to accurately predict pulmonary load in patients with pulmonary congestion.
Adverse Event Patent Pack
Download + patent application PDFs
Adverse Event Patent Applications
Download + Adverse Event-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Adverse Event-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Drug adverse event extraction method and apparatus
Nec Corporation
March 23, 2017 - N°20170083670

A method of extracting a combination of a drug and an adverse event related to the drug includes: for each of positive example combinations, negative example combinations and combinations that are neither positive examples nor negative examples, which are combinations of drug and disease, extracting medical events from medical information data about a patient and generating attribute data based on ...
Prediction and recognition of acute kidney injury after surgery
Roche Diagnostics Operations, Inc.
March 23, 2017 - N°20170082639

Systems, kits, and methods for predicting the risk of an adverse event related to acute kidney injury aki as a consequence of a surgical intervention in a subject. Embodiments of the system and methods include means and steps for determining an amount of liver-type fatty acid binding protein (l-fabp) in a sample, such as a urine-sample of a subject; comparing ...
Hydrant monitoring system and method
Silversmith, Inc.
March 16, 2017 - N°20170072238

A device for transferring adverse event information from a plurality of remote hydrants to a municipal monitoring server comprises detecting an adverse event in a hydrant that relates to an adverse hydrant condition; transferring data representative of the adverse condition to a host server by routing the data along a predefined hopping path; and transferring the data from the host ...
Method and system for the analysis and association of patient-specific and population-based genomic data with ...
Druglogic, Inc.
March 02, 2017 - N°20170061080

A method for assessing and analyzing one or more drugs, adverse effects and associated risks, and patient characteristics resulting from the use of at least drug of interest is disclosed. The method comprises the steps of selecting one or more cases for analysis, said cases describing the behavior between at least one drug of interest and a patient genotype; profiling ...
In vitro diagnostic and prognosis of major adverse events in patients undergoing coronary angiography
Immundiagnostik Ag
March 02, 2017 - N°20170059584

Method of diagnosis and prognosis of contrast media induced nephropathy (cin) comprising the steps of i) taking a urine sample from a patient exposed to the application of contrast media, notably patients subjected to coronary angiography; ii) assessing the level of vitamin d binding protein (vdbp) in the urine sample obtained in step (i); iii) relating the urinary vitamin d ...
Targeted treatment of anerobic cancer
University Hospitals Cleveland Medical Center
March 02, 2017 - N°20170056350

The present invention relates to a pharmaceutical cocktail and methods of treatment involving said cocktail, in particular, a combination of effective amounts of a carbonic anhydrase inhibitor, in combination with effective amounts of an angiogenesis inhibitor, including a vascular endothelial growth factor (vegf) inhibitor such as bevacizumab for the treatment of cancer. In other embodiments, it relates to compositions and ...
Systems and methods for predicting adverse events and assessing level of sedation during medical procedures
Children's Medical Center Corporation
February 16, 2017 - N°20170042475

Systems and methods are disclosed herein for quantitatively identifying a patient's sedation level and predicting adverse events, based on one or more capnograms or outputs from a pharmacokinetic, pharmacodynamic, or ventilatory model. A sensor measures a carbon dioxide concentration of air exhaled by a patient into a breath receiver. A processor processes the sensor data to generate a capnogram including ...
System and method for analyzing adverse event data
Astellas Pharma Europe Ltd.
February 02, 2017 - N°20170032106

A non-transitory memory is configured to store adverse event data. The adverse event data describes whether an individual experienced an adverse event as a result of being administered a therapeutic agent on each day during a time period. A processor, operatively connected to the at least one non-transitory memory, is configured to process the adverse event data and generate an ...
Loading